Europe — EMA
Norvasc (Amlodipine)
GNH USA supplies Norvasc (Amlodipine), a calcium channel blocker for hypertension and chronic stable angina. Request a quote for global supply today.
Request sourcing
What is Amlodipine?
Amlodipine, the active ingredient in Norvasc, is a calcium channel blocker presented as an oral tablet for oral use. It treats hypertension and chronic stable angina in adults.
GNH USA supplies Norvasc as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Amlodipine used for?
Norvasc is a calcium channel blocker used to manage vascular conditions.
Hypertension: lowers elevated blood pressure to reduce cardiovascular risk. Chronic stable angina: improves chest pain control by increasing coronary blood flow.
What are the side effects of Amlodipine?
Common side effects are generally mild and may resolve with continued therapy.
Common Side Effects: - Headache - Flushing - Peripheral edema - Dizziness - Fatigue - Palpitations
Serious or Rare Side Effects: - Severe hypotension - Myocardial infarction - Hepatic injury - Anaphylactic or severe allergic reactions - Arrhythmias - Angioedema
What precautions apply to Amlodipine?
Before initiating therapy, consider the following precautions. - Blood pressure monitoring: regularly assess to avoid excessive hypotension. - Hepatic impairment: use with caution and adjust dose if needed. - Concomitant antihypertensives: monitor for additive blood pressure lowering effects. - Discontinuation: avoid abrupt cessation to prevent rebound hypertension. - Pregnancy and lactation: evaluate risk‑benefit ratio with a healthcare professional. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.
What does Amlodipine interact with?
Amlodipine may interact with several drug classes; review patient medication lists.
Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase amlodipine levels. - Simvastatin >20 mg: risk of increased statin exposure and myopathy. - Grapefruit juice: can raise plasma concentrations.
Moderate Interactions (Monitor Closely):\n- CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce efficacy. - Beta‑blockers: additive effect on heart rate and blood pressure. - Diuretics: enhanced antihypertensive effect, monitor electrolytes.



